BSG and pancreatic neoplasm: In the present study, we evaluated the in vitro and in vivo properties of a novel fully human monoclonal antibody 059-053 that recognizes CD147, and labeled it with a positron emitter 89Zr, to develop a new PET probe to detect CD147 expression in pancreatic cancer.